Back to News
Market Impact: 0.15

November 7th Options Now Available For Pfizer (PFE)

PFENDAQ
Derivatives & VolatilityFutures & OptionsCompany FundamentalsMarket Technicals & FlowsInvestor Sentiment & Positioning
November 7th Options Now Available For Pfizer (PFE)

The article outlines a covered call strategy on Pfizer (PFE) stock, involving selling a $24.00 strike call with a $0.71 bid, expiring November 7th, against PFE shares currently trading at $23.86. This strategy offers a potential 3.56% return if the stock is called away, or a 2.98% premium retention (25.23% annualized YieldBoost) with a 48% probability if the option expires worthless. A notable observation is the contract's implied volatility of 51%, which significantly surpasses PFE's 25% trailing twelve-month actual volatility, indicating a potential divergence in market expectations versus historical price movements.

Analysis

An analysis of a covered call strategy on Pfizer (PFE) reveals an opportunity to generate yield with a defined risk profile. The strategy involves purchasing shares at the current price of $23.86 and selling the November 7th expiration call option with a $24.00 strike price, collecting a premium of $0.71 per share. This presents two primary outcomes: if PFE closes above $24.00 at expiration, the position yields a total return of 3.56% (before commissions) as the shares are called away. Alternatively, if the option expires worthless—an outcome with a current estimated probability of 48%—the investor retains the shares and the 71-cent premium, resulting in a 2.98% return boost, which annualizes to a 25.23% "YieldBoost." A critical observation is the significant discrepancy between the option's implied volatility of 51% and the stock's trailing twelve-month actual volatility of 25%. This suggests that option sellers are being compensated with a premium that reflects expectations of future price movement far exceeding historical trends, presenting a potentially advantageous scenario for those selling volatility.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo